Weekly Digest – 29 Apr-05 May 2023 Weekly Digest – 29 Apr-05 May 2023 May 03, 2023: Elahere / FRα-Positive Platinum-Resistant Ovarian Cancer / Immunogen: Phase 3 MIRASOL trial demonstrated improved clinical benefits Immunogen announced positive top-line data from the […]
Weekly Digest – 29 Apr-05 May 2023 Weekly Digest – 29 Apr-05 May 2023 May 03, 2023: Breyanzi (IV) / R/R Large B-cell Lymphoma / BMS: Received EU approval EU approval of Breyanzi was based on the positive data from […]
Weekly Digest – 29 Apr-05 May 2023 Weekly Digest – 29 Apr-05 May 2023 May 01, 2023: Breyanzi (IV) / R/R Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL) / BMS: TRANSCEND FL and TRANSCEND NHL 001 studies met primary […]
Weekly Digest – 29 Apr-05 May 2023 Weekly Digest – 29 Apr-05 May 2023 April 29, 2023: Xtandi (IV) and Leuprolide (IV) / Non-Metastatic Hormone-Sensitive Prostate Cancer / Pfizer: Reduced the Risk of Metastasis Positive data reported from the Phase […]
